BUSINESS
Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
CNBC BusinessMonday, November 9, 2026 at 2:30 PM
RedScroll Brief
Lilly plans to file by the end of the year for U. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
RedScroll Signal
- Impact
- High
- Category
- Business
- Market relevance
- High
- Why it matters
- Corporate and market moves reprice risk and reveal where power and cash are concentrating. Lilly plans to file by the end of the year for U. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity. Investors will watch earnings, rates, and competitive positioning connected to Eli Lilly and Foundayo.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Lilly plans to file by the end of the year for U. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Why it matters
Corporate and market moves reprice risk and reveal where power and cash are concentrating.
Background
CNBC Business reported on this under business. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
CNBC Business published: Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Investors will watch earnings, rates, and competitive positioning connected to Eli Lilly and Foundayo.
More on
Related stories
- Can Nvidia’s boss survive a Chinese-spy controversy?
The Economist BusinessBUSINESS
- YouTube’s dominance has Hollywood running scared
The Economist BusinessBUSINESS
- America’s copper giant has big dreams—but cautious plans
The Economist BusinessBUSINESS
- US Natural Gas Jumps as Cooler Forecasts Trigger Short Covering
Bloomberg MarketsBUSINESS
- Fox Holds Investor Calls Before Planned Bond Sale for Roku Deal
Bloomberg MarketsBUSINESS
- Peloton Taps Junk-Bond Market for First Time in Refinancing Deal
Bloomberg MarketsBUSINESS
Source
CNBC Business
Original reporting by CNBC Business. RedScroll provides an extractive briefing only.